Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 12, 2003 - Issue 7
Submit an article Journal homepage
21
Views
3
CrossRef citations to date
0
Altmetric
Review

Pharmacological methods to overcome IFN-β antibody formation in the treatment of multiple sclerosis

Francesca Bagnato Neuroimmunology Branch, National Institutes of Neurological Disease and Stroke, National Institutes of Health, Building 10, Room 5B16, 10 Center Drive MSC 1400, Bethesda, MD, 20892-1400 USA. [email protected]
&
Carlo Pozzilli Neuroimmunology Branch, National Institutes of Neurological Disease and Stroke, National Institutes of Health, Building 10, Room 5B16, 10 Center Drive MSC 1400, Bethesda, MD, 20892-1400 USA. [email protected]
Pages 1153-1163 | Published online: 02 Mar 2005

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Francesca Bagnato, Marco Riva & Guido Antonelli. (2006) Neutralising antibodies to IFN-β in patients with multiple sclerosis. Expert Opinion on Biological Therapy 6:8, pages 773-785.
Read now

Articles from other publishers (2)

A W Chiu, M Ehrmantraut, N D Richert, V N Ikonomidou, S Pellegrini, H F McFarland, J A Frank & F Bagnato. (2007) A case study on the effect of neutralizing antibodies to interferon beta 1b in multiple sclerosis patients followed for 3 years with monthly imaging. Clinical and Experimental Immunology 150:1, pages 61-67.
Crossref
Bernhard Hemmer, Olaf Stüve, Bernd Kieseier, Huub Schellekens & Hans-Peter Hartung. (2005) Immune response to immunotherapy: the role of neutralising antibodies to interferon beta in the treatment of multiple sclerosis. The Lancet Neurology 4:7, pages 403-412.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.